Revenue: $2,308,000,000; Cost of Revenue: $1,621,000,000; Gross Profit: $687,000,000; Gross Margin: 29.77%
R&D Expense: $316,000,000; SG&A/Selling, General & Administrative: $179,000,000; Other Expenses: $16,000,000; Operating Expenses: $511,000,000; Cost and Expenses: $2,132,000,000; EBIT (Operating Income): $176,000,000; EBIT Margin: 7.63%
Interest Expense: $16,000,000; EBITDA: $176,000,000; EBITDA Margin: 7.63%
Income Before Tax: $124,000,000; Income Tax Expense: $12,000,000; Net Income: $112,000,000; Net Margin: 4.85%
Weighted Average Shares Outstanding: 146,000,000 (basic); 149,000,000 (diluted); EPS: Not reported
Cash Flow: Net Income $112,000,000; Depreciation & Amortization: $36,000,000; Stock-Based Compensation: $53,000,000; Change in Working Capital: Not provided; CFO: $488,000,000; Capex: $50,000,000; Free Cash Flow: $438,000,000; Net Cash Provided by Operating Activities: $488,000,000; Net Cash Used in/Provided by Financing Activities: -$515,000,000; Net Change in Cash: -$39,000,000; Cash at End of Period: $1,442,000,000; Cash at Beginning of Period: $1,481,000,000; Operating Cash Flow: $488,000,000
Balance Sheet: Total Assets $12.749B; Total Liabilities $3.368B; Total Stockholders’ Equity $9.381B; Cash and Cash Equivalents $1.442B; Short-Term Investments: N/A; Accounts Receivable $1.265B; Inventory $1.908B; Current Assets $4.984B; Property, Plant & Equipment (Net) $0.630B; Goodwill $4.999B; Total Current Liabilities $1.516B; Long-Term Debt $1.331B; Total Debt $1.351B; Net Debt: -$91,000,000